CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.
CASS Pharmaceuticals has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in October 2022.
CASS Pharmaceuticals is headquartered in Franklin, United States.
CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.
CASS Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CASS Pharmaceuticals — Funding & Investors." VCBacked, October 21, 2022, https://www.vcbacked.co/company/cass-pharmaceuticals. Accessed August 15, 2026.
VCBacked. (2022). CASS Pharmaceuticals — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cass-pharmaceuticals
{{cite web |title=CASS Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cass-pharmaceuticals |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated